Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 배상철 | - |
dc.date.accessioned | 2019-12-10T19:17:30Z | - |
dc.date.available | 2019-12-10T19:17:30Z | - |
dc.date.issued | 2018-12 | - |
dc.identifier.citation | JOURNAL OF KOREAN MEDICAL SCIENCE, v. 33, no. 52, Article no. UNSP e346 | en_US |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.issn | 1598-6357 | - |
dc.identifier.uri | https://jkms.org/DOIx.php?id=10.3346/jkms.2018.33.e346 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/121092 | - |
dc.description.abstract | Background: To evaluate the therapeutic benefits of the treat-to-target (T2T) strategy for Asian patients with early rheumatoid arthritis (RA) in Korea.Methods: In a 1-year, multicenter, open-label strategy trial, 346 patients with early RA were recruited from 20 institutions across Korea and stratified into 2 groups, depending on whether they were recruited by rheumatologists who have adopted the T2T strategy (T2T group) or by rheumatologists who provided usual care (non-T2T group). Data regarding demographics, rheumatoid factor titer, anti-cyclic citrullinated peptide antibody titer, disease activity score of 28 joints (DAS28), and Korean Health Assessment Questionnaire (KHAQ) score were obtained at baseline and after 1 year of treatment. In the T2T group, the prescription for disease-modifying antirheumatic drugs was tailored to the predefined treatment target in each patient, namely remission (DAS28 < 2.6) or low disease activity (LDA) (2.6 <= DAS28 < 3.2).Results: Data were available for 163 T2T patients and 162 non-T2T patients. At the end of the study period, clinical outcomes were better in the T2T group than in the non T2T group (LDA or remission, 59.5% vs. 35.8%; P < 0.001; remission, 43.6% vs. 19.8%; P < 0.001). Compared with non-T2T, T2T was also associated with higher rate of good European League Against Rheumatism response (63.0% vs. 39.8%; P < 0.001), improved KHAQ scores (-0.38 vs. -0.13; P= 0.008), and higher frequency of follow-up visits (5.0 vs. 2.0 visits/year; P < 0.001).Conclusion: In Asian patients with early RA, T2T improves disease activity and physical function. Setting a pre-defined treatment target in terms of DAS28 is recommended. | en_US |
dc.description.sponsorship | Funded by AbbVie Korea from 2013 to 2015. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | en_US |
dc.subject | Rheumatoid Arthritis | en_US |
dc.subject | Treatment Outcome | en_US |
dc.subject | Treat-to-target | en_US |
dc.title | Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea | en_US |
dc.type | Article | en_US |
dc.relation.no | 52 | - |
dc.relation.volume | 33 | - |
dc.identifier.doi | 10.3346/jkms.2018.33.e346 | - |
dc.relation.page | 1-11 | - |
dc.relation.journal | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.contributor.googleauthor | Song, Jason Jungsik | - |
dc.contributor.googleauthor | Song, Yeong Wook | - |
dc.contributor.googleauthor | Bae, Sang Cheol | - |
dc.contributor.googleauthor | Cha, Hoon-Suk | - |
dc.contributor.googleauthor | Choe, Jung-Yoon | - |
dc.contributor.googleauthor | Choi, Sung Jae | - |
dc.contributor.googleauthor | Kim, Hyun Ah | - |
dc.contributor.googleauthor | Kim, Jinseok | - |
dc.contributor.googleauthor | Kim, Sung-Soo | - |
dc.contributor.googleauthor | Lee, Choong-Ki | - |
dc.relation.code | 2018003141 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | scbae | - |
dc.identifier.orcid | https://orcid.org/0000-0003-4658-1093 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.